Milman Sofiya, Barzilai Nir
Department of Medicine, Division of Endocrinology, Albert Einstein College of Medicine, New York, New York 10461 Institute for Aging Research, Albert Einstein College of Medicine, New York, New York 10461.
Department of Medicine, Division of Endocrinology, Albert Einstein College of Medicine, New York, New York 10461 Institute for Aging Research, Albert Einstein College of Medicine, New York, New York 10461 Department of Genetics, Albert Einstein College of Medicine, Bronx, New York 10461.
Cold Spring Harb Perspect Med. 2015 Dec 4;6(1):a025098. doi: 10.1101/cshperspect.a025098.
Humans age at different rates and families with exceptional survival provide the opportunity to understand why some people age slower than others. Unique features exhibited by centenarians include a family history of longevity, compression of morbidity with resultant extension of health span, and biomarkers such as low-circulating insulin-like growth factor 1 (IGF-1) and elevated high-density lipoprotein (HDL) cholesterol levels. Given the rarity of the centenarian phenotype, it has not been surprising that the use of discovery methods that relied on common population single nucleotide polymorphisms (SNPs) to unlock the genetic determinants of exceptional longevity have not yielded significant results. Conversely, gene sequencing has resulted in discoveries of functional gene variants that support several of the centenarian phenotypes. These discoveries have led to the strategic developments of drugs that may delay aging and prolong health span.
人类衰老的速度各不相同,拥有超常寿命的家族为我们提供了契机,去了解为何有些人比其他人衰老得更慢。百岁老人所展现出的独特特征包括长寿家族史、发病期缩短从而使健康期延长,以及一些生物标志物,如循环胰岛素样生长因子1(IGF-1)水平较低和高密度脂蛋白(HDL)胆固醇水平升高。鉴于百岁老人这一表型十分罕见,依靠普通人群单核苷酸多态性(SNP)来揭示超常寿命的遗传决定因素的发现方法未取得显著成果也就不足为奇了。相反,基因测序已发现了一些功能性基因变异,这些变异支持了百岁老人的几种表型。这些发现推动了可能延缓衰老和延长健康期的药物的战略研发。